Jeff Ajer BioMarin

Jeff Ajer joined BioMarin in August 2005 and currently serves as Executive Vice President and Chief Commercial Officer. From October 2012 to January 2014, Mr. Ajer served as BioMarin's, Senior Vice President and Chief Commercial Officer. From April 2009 to October 2012, Jeff also served as BioMarin's, Vice President, Commercial Operations, The Americas, where he had responsibility for commercial operations throughout the Americas and led product marketing, reimbursement, and sales operations.

Prior to joining BioMarin, he served in various roles at Genzyme Corporation (Genzyme) beginning in November 2003, most recently as Vice President, Global Transplant Operations from December 2004 to August 2005. Mr. Ajer’s experience prior to Genzyme includes roles in sales, marketing, and operations at SangStat Medical Corporation and ICN Pharmaceuticals.

Mr. Ajer received both a B.S. in chemistry and an M.B.A. from the University of California, Irvine.

He is also currently a director of Nektar Therapeutics, a public biopharmaceutical company.